Oxford Financial Group LTD. LLC Invests $713,000 in Stryker Corporation $SYK

Oxford Financial Group LTD. LLC purchased a new position in shares of Stryker Corporation (NYSE:SYK) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 2,266 shares of the medical technology company’s stock, valued at approximately $713,000.

Several other institutional investors have also recently bought and sold shares of SYK. Gables Capital Management Inc. bought a new stake in shares of Stryker during the second quarter worth $25,000. Kilter Group LLC acquired a new stake in shares of Stryker in the second quarter valued at $25,000. Godfrey Financial Associates Inc. bought a new position in shares of Stryker in the fourth quarter valued at about $26,000. Sankala Group LLC acquired a new position in Stryker during the 4th quarter worth about $26,000. Finally, United Financial Planning Group LLC acquired a new position in Stryker during the 3rd quarter worth about $27,000. Institutional investors own 77.09% of the company’s stock.

Stryker Stock Down 3.5%

Shares of Stryker stock opened at $327.97 on Friday. Stryker Corporation has a 12 month low of $281.00 and a 12 month high of $396.86. The business has a fifty day simple moving average of $326.64 and a 200 day simple moving average of $332.66. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. The stock has a market cap of $125.80 billion, a PE ratio of 33.99, a price-to-earnings-growth ratio of 2.17 and a beta of 0.76.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.49 by $0.20. The firm had revenue of $6.59 billion for the quarter, compared to analysts’ expectations of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The company’s revenue was up 9.4% compared to the same quarter last year. During the same quarter last year, the business earned $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Research analysts predict that Stryker Corporation will post 15.02 EPS for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.88 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s dividend payout ratio (DPR) is presently 36.48%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. BTIG Research lowered their price objective on shares of Stryker from $371.00 to $358.00 and set a “buy” rating for the company in a research report on Friday, July 31st. Canaccord Genuity Group reduced their target price on shares of Stryker from $435.00 to $400.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. UBS Group initiated coverage on shares of Stryker in a research note on Tuesday, July 28th. They set a “buy” rating and a $400.00 price target on the stock. Needham & Company LLC lowered their price target on shares of Stryker from $454.00 to $418.00 and set a “buy” rating for the company in a report on Friday, May 1st. Finally, Sanford C. Bernstein set a $410.00 price objective on shares of Stryker in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $386.28.

Insider Activity at Stryker

In other Stryker news, insider Debra King sold 826 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total value of $277,783.80. Following the completion of the sale, the insider owned 6,210 shares of the company’s stock, valued at approximately $2,088,423. This represents a 11.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Robert S. Fletcher sold 4,544 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the completion of the sale, the vice president owned 10,582 shares in the company, valued at approximately $3,247,298.34. This trade represents a 30.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 665,370 shares of company stock worth $216,238,501. 4.60% of the stock is currently owned by company insiders.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.